Christine Palmer

Company: Gritstone Bio
Job title: Director, Clinical Immunology
Seminars:
A Novel Heterologous Prime Boost Vaccine System To Drive Tumor Specific T Cell Responses For Cancer Immunotherapy 10:00 am
Development of a potent heterologous prime/boost immunization approach to deliver predicted TSNAs to patients, which is comprised of a replication incompetent chimpanzee adenoviral vector (ChAdV) for the prime vaccination and a self-replicating, synthetic viral vector (srRNA) for repeated boost vaccinations Induction of high titer, polyfunctional and durable T-cell responses against nonself antigens Clinical trial updates…Read more
day: Day One